Antimitotic Agents: all 5,052 studies that test it
Page 39 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single AgentTerminatedNCT00620100Phase 2
- Study of Sorafenib and Docetaxel in Metastatic Prostate CancerCompletedNCT00619996Phase 2
- GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerCompletedNCT00617968Phase 2
- Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityCompletedNCT00617370Not applicable
- Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00616031Phase 2
- Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast CancerCompletedNCT00615602Phase 3
- Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the UterusCompletedNCT00614835Not applicable
- A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult PatientsCompletedNCT00613652Phase 1
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00613457Phase 3
- Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinCompletedNCT00611962Phase 2
- Phase 1 Study of MPC-6827 and Temozolomide in Metastatic MelanomaCompletedNCT00609011Phase 1/2
- A Study of Ispinesib in Metastatic Breast CancerTerminatedNCT00607841Phase 1
- A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial CancerCompletedNCT00607607Phase 2
- A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast CancerTerminatedNCT00607438Phase 2
- Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00606814Phase 1
- Pharmacokinetics Study of Liposomal Paclitaxel in HumansCompletedNCT00606515Phase 4
- Neoadjuvant Endostatin and Chemotherapy for Breast CancerCompletedNCT00604435Phase 2
- Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.CompletedNCT00600249Phase 2
- Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the ProstateWithdrawnNCT00598858Phase 2
- The Synergism Or Long Duration (SOLD) StudyCompletedNCT00593697Phase 3
- Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) ScansCompletedNCT00591890Phase 1
- Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid TumorsCompletedNCT00591383Phase 1
- Phase I Study in Advanced Solid TumorsCompletedNCT00591292Phase 1
- Phase I Study of Indibulin in Patients With Solid TumorsCompletedNCT00591136Phase 1
- Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric CancerStatus unknownNCT00587145Phase 2
- Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung CancerCompletedNCT00582634Phase 2
- Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate CancerTerminatedNCT00582582Phase 2
- Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
- Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
- Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)Status unknownNCT00575796Phase 2
- Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerCompletedNCT00574769Phase 1/2
- A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00571675Phase 2
- Study of Weekly DCF to Treat Advanced Gastric CancerTerminatedNCT00568971Phase 2
- Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00568646Phase 2
- Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast CancerCompletedNCT00567554Phase 3
- Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.TerminatedNCT00565227Phase 1
- Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast CancerCompletedNCT00561119Phase 3
- Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate CancerCompletedNCT00559429Phase 1
- Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck CancerTerminatedNCT00557206Phase 2
- LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid TumorsCompletedNCT00556088Phase 1
- Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone TherapyCompletedNCT00554918Phase 2
- A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic CancerTerminatedNCT00553813Phase 2
- Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell TumorsStatus unknownNCT00551122Phase 1/2
- Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00550784Phase 1
- Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory CancerTerminatedNCT00547261Phase 1
- A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer PatientsCompletedNCT00545246Phase 1
- A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung CancerCompletedNCT00544960Phase 2
- Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)CompletedNCT00544232Phase 3
- PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneCompletedNCT00544219Not applicable
- German Preoperative Adriamycin Docetaxel StudyCompletedNCT00543829Phase 2
- A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic MetastasesCompletedNCT00542048Phase 2
- Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's SarcomaStatus unknownNCT00541411Not applicable
- Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic CancerCompletedNCT00541281Phase 2
- BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast CancerCompletedNCT00540800Phase 3
- A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)TerminatedNCT00539968Phase 1/2
- TAX + Carboplatin or Cisplatin 1st Line Post-Surgery OvarianCompletedNCT00539669Phase 2
- TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHNCompletedNCT00539630Phase 3
- A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain CancerCompletedNCT00539383Phase 1
- A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant GliomaCompletedNCT00539344Phase 1
- Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast CancerCompletedNCT00538525Not applicable
- Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast CancerStatus unknownNCT00538395Not applicable
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerCompletedNCT00535119Phase 1
- A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced CancerWithdrawnNCT00534807Phase 1
- BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
- A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric CancerCompletedNCT00533533Phase 1/2
- Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and TrastuzumabCompletedNCT00532857Phase 2
- Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast CancerCompletedNCT00532623Phase 2
- Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell CancerTerminatedNCT00531687Phase 2
- ABI-008 Trial in Patients With Metastatic Breast CancerTerminatedNCT00531271Phase 1/2
- Taxotere/Temodar/Cisplatin Study in Melanoma PatientsCompletedNCT00527761Phase 1
- Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/DocetaxelCompletedNCT00527449Phase 2
- Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast CancerCompletedNCT00525759Phase 2
- p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal CancerCompletedNCT00525200Phase 3
- Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric CancerCompletedNCT00525005Phase 2
- Liposomal Doxorubicin and Docetaxel in Metastatic Breast CancerCompletedNCT00524810Phase 2
- Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in MelanomaTerminatedNCT00522834Phase 3
- Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate CancerTerminatedNCT00521781Phase 2
- Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck CancerCompletedNCT00521521Phase 2
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00520000Phase 1
- Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This QuestionnaireCompletedNCT00517621Phase 2
- Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and CisplatinTerminatedNCT00516750Phase 2
- Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelCompletedNCT00516724Phase 1
- Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast CancerCompletedNCT00513058Phase 1
- PVAG-14 Pilot for Intermediate Stages Hodgkin LymphomaTerminatedNCT00512980Phase 2
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNCT00511576Phase 1
- Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)CompletedNCT00511485Phase 2
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric CancerCompletedNCT00511446Phase 2
- N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk NeuroblastomaCompletedNCT00509353Phase 1
- Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver InvolvementCompletedNCT00508326Phase 1
- Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)CompletedNCT00507741Phase 2
- A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic MalignanciesCompletedNCT00506402Phase 1
- Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/ChemotherapyTerminatedNCT00505492Phase 2
- Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory CancerCompletedNCT00504790Phase 1
- Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical TrialCompletedNCT00502463Not applicable
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWithdrawnNCT00499291Not applicable
- Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersCompletedNCT00498979Phase 1
- Phase I Study of Patupilone and RAD001CompletedNCT00496600Phase 1
- Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCompletedNCT00496275Phase 1
- Phase I Study in Patients With Solid TumoursCompletedNCT00496028Phase 1
- Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate CancerTerminatedNCT00494338Phase 2